Micro- and nanoscale technologies for tissue engineering and drug discovery applications

Micro- and nanoscale technologies are emerging as powerful enabling tools for tissue engineering and drug discovery. In tissue engineering, micro- and nanotechnologies can be used to fabricate biomimetic scaffolds with increased complexity and vascularization.

The whole 16 pages article is available for download here.   

Natural products as a gold mine for arthritis treatment

Arthritis, an inflammation of the joints, is usually a chronic disease that results from dysregulation of pro-inflammatory cytokines (e.g. tumour necrosis factor and interleukin-1b) and pro-inflammatory enzymes that mediate the production of prostaglandins (e.g. cyclooxygenase-2) and leukotrienes
(e.g. lipooxygenase), together with the expression of adhesion molecules and matrix metalloproteinases, and hyperproliferation of synovial fibroblasts. All of these factors are regulated by the activation of the transcription factor nuclear factor-kB. Thus, agents that suppress the expression of tumour necrosis factor-a, interleukin-1b, cyclooxygenase-2, lipooxygenase, matrix metalloproteinases or adhesion molecules, or suppress the activation of NF-kB, all have potential for the treatment of arthritis.

The whole 8 pages article is available for download here

A Comprehensive Review on Nanoparticle Drug Delivery System

Nanoparticles (NP) are defined as particles with a diameter smaller than 100 nm, are increasingly used in different applications, including drug carrier systems and to pass organ barriers such as the blood-brain barrier. Because of their unique properties Nanocrystals (quantum dots) and other nanoparticles (gold colloids, nanobars, dendrimers and nanoshells) have been receiving a lot of attention for potential use in Therapeutics, Bioengineering and therapeutics drug discovery.

The whole 17 pages article is available for download here.

6th International Conference on Food and Beverages

Conference: February 19th - 20th, 2020 (Dubai, UAE)

The main aim of food and beverage conference is to provide a premium interdisciplinary podium to build up a network from the grass root to the apical top among the people allied to food science, scientific researches as well as future of food technologies and their interconnected fields.

Disruptive Technologies in Pharma

Conference: January 20th - 21th, 2020 (London, UK)
Workshop: January 22nd, 2020 (London, UK)

The conference aims to bring together experts of emerging technologies to discover the opportunities with regards to Artificial intelligence, Machine Learning, Internet of Things, Digital therapeutics, eHealth and blockchain. The effect of these technologies on the industry will be discussed with the aim to highlight challenges related to the implementation of these new technologies and to discuss how to overcome them.

GSK and Online Communities Create Unique Alliance to Stimulate Open Source Drug Discovery for Malaria

  • GSK becomes first company to freely share chemical structures on 13,500 molecules from its compound library
  • Alliances formed with leading scientific research communities from private industry and public-domain data provider
Logos
May 19, 2010/Burlingame, CA/ GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the US-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria. 

Featured Events


P 298 Biosimilars 150x150
150x150
 bio150
DISRUPTIVE TECHNOLOGIES IN PHARMA 150x150 copy
6th International Conference on Food and Beverages 150x150